Clinical Trial Update: Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating induction chemotherapy with afatinib, ribavirin, and weekly carboplatin/paclitaxel for HPV-associated stage IVA/IVB oropharyngeal squam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Oropharyngeal Squamous Cell Carcinoma

Drugs mentioned

• Copegus (ribavirin)
• Gilotrif (Afatinib)
• Paraplatin (Carboplatin)
• Taxol (paclitaxel)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Head and Neck Cancer, Squamous Cell Cancer | Phase 1 | Status: COMPLETED